Committee on the Evaluation of the Department of Defense Comprehensive Clinical Evaluation Program, Institute of Medicine

Select Guide Rating

• 1 FRONT MATTER; 2 EXECUTIVE SUMMARY; 3 INTRODUCTION; 4 THE COMPREHENSIVE CLINICAL EVALUATION PROGRAM; 5 TESTING FOR AND IDENTIFYING HEALTH EFFECTS OF EXPOSURE TO NERVE AGENTS; 6 RECOMMENDATIONS; 7 REFERENCES; 8 APPENDIX A; 9 APPENDIX B; 10 APPENDIX C; 11 APPENDIX D; 12 APPENDIX E

Committee on the Evaluation of the Department of Defense Comprehensive Clinical Evaluation Program, Institute of Medicine

Select Guide Rating

• 1 FRONT MATTER; 2 EXECUTIVE SUMMARY; 3 INTRODUCTION; 4 THE COMPREHENSIVE CLINICAL EVALUATION PROGRAM; 5 TESTING FOR AND IDENTIFYING HEALTH EFFECTS OF EXPOSURE TO NERVE AGENTS; 6 RECOMMENDATIONS; 7 REFERENCES; 8 APPENDIX A; 9 APPENDIX B; 10 APPENDIX C; 11 APPENDIX D; 12 APPENDIX E

Committee on the Evaluation of the Department of Defense Comprehensive Clinical Evaluation Program, Institute of Medicine

Select Guide Rating

• 1 FRONT MATTER; 2 EXECUTIVE SUMMARY; 3 INTRODUCTION; 4 THE COMPREHENSIVE CLINICAL EVALUATION PROGRAM; 5 TESTING FOR AND IDENTIFYING HEALTH EFFECTS OF EXPOSURE TO NERVE AGENTS; 6 RECOMMENDATIONS; 7 REFERENCES; 8 APPENDIX A; 9 APPENDIX B; 10 APPENDIX C; 11 APPENDIX D; 12 APPENDIX E